Hongming Chen Email and Phone Number
Hongming Chen work email
- Valid
- Valid
- Valid
Hongming Chen personal email
Hongming Chen phone numbers
Seasoned biotech/pharmaceutical executive and successful serial entrepreneur with a proven track record in building/leading organizations, developing innovative technologies/products, raising capital, and creating values for investors/share holders. Successfully started and exited two biotech companies: TransForm Pharmaceuticals (acquired by J&J) and Kala Pharmaceuticals (IPO-ed)• National Academy of Engineering Member• National Academy of Engineering Bioengineering Peer Committee Member• National Academy of Engineering Bio/Pharma Subcommittee Member• National Academy of Medicine Emerging Leaders Forum Member• American Institute for Medical and Biological Engineering Elected Fellow• Controlled Release Society Elected Fellow• Member of the UT Austin Academy of Distinguished Chemical Engineers• UT Austin Cockrell School of Engineering Distinguished Graduate Awardee• The 2020 MIT Alan S. Michaels Distinguished Lectureship in Medical and Biological Engineering• Named one of 2014’s “Women to Watch” by Mass High Tech and Boston Business Journal• Rang the Opening Bell at NASDAQ on behalf of Kala• Prolific inventor with numerous issued patents
-
President, Head Of R And DMetis TherapeuticsUnited States
-
President, Head Of R&DMetis Therapeutics Dec 2021 - PresentCambridge, Ma, UsResponsible for R&D, business strategy, and general operations for METiS Therapeutics., Inc.
-
Board Member, Metis Pharmaceuticals (剂泰医药)Metis Therapeutics Oct 2019 - PresentCambridge, Ma, UsMember of the Board of Directors.
-
Chief Scientific OfficerKala Pharmaceuticals Jan 2010 - Dec 2021Arlington, Massachusetts, UsStarted Kala in late 2009, built the company and team from scratch. Translated an academic technology to two FDA-approved products (INVELTYS and EYSUVIS). Responsible for R&D activities from preclinical to regulatory approval. Raised >$120 MM in private capital, and successfully IPO-ed the company with a raise of $104 MM in 2017. Rang the Opening Bell on behalf of Kala at the NASDAQ Market Site. -
Scientific Advisory Board, Xtalpi (晶泰科技）Xtalpi Inc. Mar 2018 - Apr 2020Cambridge, Massachusetts, UsServed as a scientific advisor for pharmaceuticals development and pipeline assessment. -
Direct Of Convergent Products (Post Acquisition Of Transform Pharmaceuticals)Johnson & Johnson Mar 2005 - Jan 2010New Brunswick, Nj, UsDevelopment of complex, combination products such as computer-assisted anesthetics, transdermal patches, drug-loaded ocular punctal plugs, etc. Led collaborations with other JnJ family of companies such as Alza, Vistakon, Ethicon Endo Surgery, etc. -
Director Formulation DevelopmentTransform Pharmaceuticals (Acquired By Johnson & Johnson In 2005) Dec 1999 - Mar 2005Started TransForm in late 1999, and grew the company to its acquisition in 2005 by J&J for $230 MM. Built company's core high throughput form and formulation technology platforms, designed novel drug formulations, collaborated with strategic partners (Lilly, J&J, etc.), and developed proprietary drug products. Led the development of PropoClear (emulsion free Propofol) through FDA approval, as well as several other late stage (Phase II/III) programs.
-
ScientistAstrazeneca Jul 1997 - Dec 1999Cambridge, Cambridgeshire, GbResponsible for developing new formulations and delivery vehicles for recombinant H. pylori proteins for oral vaccination. Led team collaboration across multiple global sites. -
Consulting AdvisorOrasomal Technologies 1996 - 1999Provided technical consultation to Orasomal, a company formed based on my MIT thesis.
-
Sr. Process EngineerMerck Dec 1996 - Jul 1997Rahway, New Jersey, UsResponsible for technical assessment and process improvement for sterile-filled and lyophilized biologic products. Also led process improvement and validation efforts for life-cycle management of marketed products.
Hongming Chen Skills
Hongming Chen Education Details
-
Massachusetts Institute Of TechnologyChemical Engineering -
Harvard UniversityBusiness Program
-
Massachusetts Institute Of TechnologyChemical Engineering
-
The University Of Texas At AustinChemical Engineering
-
Fudan UniversityCandidate For B.S. In Material Science
Frequently Asked Questions about Hongming Chen
What company does Hongming Chen work for?
Hongming Chen works for Metis Therapeutics
What is Hongming Chen's role at the current company?
Hongming Chen's current role is President, Head of R and D.
What is Hongming Chen's email address?
Hongming Chen's email address is ho****@****arx.com
What is Hongming Chen's direct phone number?
Hongming Chen's direct phone number is +178164*****
What schools did Hongming Chen attend?
Hongming Chen attended Massachusetts Institute Of Technology, Harvard University, Massachusetts Institute Of Technology, The University Of Texas At Austin, Fudan University.
What skills is Hongming Chen known for?
Hongming Chen has skills like Biotechnology, Drug Delivery, R&d, Drug Discovery, Drug Development, Pharmaceutical Industry, Technology Transfer, Lifesciences, Formulation, Biopharmaceuticals, Hplc, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial